Skip to content

US · CGO

Calamos Global Total Return Fund

Sector
Financial Services · Asset Management - Global
Headquarters
Naperville, IL 60563-2787

Price · as of 2026-10-18

$11.60

Market cap 127.46M

Price history

The price history chart is shown only to users with a Pro subscription.

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Calamos Global Total Return Fund (CGO) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

The valuation history chart is shown only to users with a Pro subscription.

Historic valuation ratios

Pick a category, then toggle metrics to compare.

Historic valuation ratios are shown only to users with a Pro subscription.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Calamos Global Total Return Fund

        The Calamos Global Total Return Fund is a U.S.-domiciled, balanced, closed-end mutual fund that originated from Calamos Investments LLC and is overseen by Calamos Advisors LLC. Established on March 30, 2004, this fund strategically allocates capital across international public equity and fixed-income markets. Its investment objective is to identify opportunities in securities issued by companies spanning a diverse range of sectors. The portfolio predominantly comprises common stocks, convertible bonds, and high-yield corporate debt instruments. To construct its holdings, the fund integrates thorough fundamental research with systematic quantitative analysis. The Calamos Global Total Return Fund measures its investment performance against the MSCI World Index.

        CEO
        John Peter Calamos
        Employees
        0
        Beta
        1.11

        Peer comparison

        Same-industry comparables, ranked by market cap.

        The peer comparison table is shown only to users with a Pro subscription.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.